The Timolol Market is a vital segment within the pharmaceutical industry, primarily driven by the increasing prevalence of glaucoma and other cardiovascular diseases. Timolol, a non-selective beta-adrenergic antagonist, is widely used in ophthalmology to reduce intraocular pressure in patients with glaucoma and ocular hypertension. It is also used in cardiology to manage...